HomeTRML • NASDAQ
Tourmaline Bio Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.97M | 18.22% |
Net income | -23.09M | -32.05% |
Net profit margin | — | — |
Earnings per share | -0.90 | -32.35% |
EBITDA | -25.96M | -18.22% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 239.23M | -17.37% |
Total assets | 269.30M | -21.90% |
Total liabilities | 10.10M | 55.22% |
Total equity | 259.19M | — |
Shares outstanding | 25.69M | — |
Price to book | 2.28 | — |
Return on assets | -23.32% | — |
Return on capital | -24.08% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -23.09M | -32.05% |
Cash from operations | -20.26M | -12.53% |
Cash from investing | 16.30M | 260.92% |
Cash from financing | 54.00K | — |
Net change in cash | -3.91M | 86.11% |
Free cash flow | -12.27M | -2.63% |
Previous close
$23.03
Day range
$22.31 - $23.42
Year range
$11.56 - $29.79
Market cap
613.86M USD
Avg Volume
184.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2021
Website
Employees
76
